Exacerbation of alcoholic liver injury by enteral endotoxin in rats.
Increased gut permeability (leaky gut) and endotoxin-mediated Kupffer cell activation are proposed as the mechanisms of alcoholic liver injury. Although ethanol feeding is shown to sensitize the liver for injury induced by parental administration of lipopolysaccharide (LPS), how enteral LPS loading affects alcoholic liver injury is yet to be tested. The present study provides direct evidence for enhanced entrance to portal circulation of LPS enterally administered to the intragastric ethanol infusion model. Portal and systemic blood endotoxin levels increased to 43.0 +/- 4.1 and 6.2 +/- 4.3 pg/mL at 2 hours following enteral LPS administration (5 mg/kg) in alcohol-fed animals, while no such increases were observed in pair-fed controls. However, endotoxin levels in systemic blood of alcohol-fed rats were reduced to 0 to 1. 5 pg/mL 16 hours after LPS administration. Weekly enteral administration of LPS to the model for 9 weeks exacerbated an increase in plasma alanine transaminase (ALT) levels (227 +/- 75 vs. 140 +/- 70; P <.01), mononuclear infiltration (25 +/- 22 vs. 6.4 +/- 4.4/10 mm(2); P =.02), sinusoidal congestion, and spotty necrosis, and induced diffuse coagulative necrosis and centrilobular fibrosis in some animals. Reverse-transcription polymerase chain reaction (RT-PCR) analysis confirmed the LPS effect at the tissue level by demonstrating accentuated induction of tumor necrosis factor alpha (TNF-alpha) and Cox-2 mRNA. In conclusion, enteral LPS administration potentiates alcoholic liver necrosis, inflammation, and fibrosis despite efficient endotoxin clearance by the liver and mild systemic endotoxemia that occurs episodically following enteral LPS challenge.
Mathurin
P
P
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Deng
Q G
QG
Keshavarzian
A
A
Choudhary
S
S
Holmes
E W
EW
Tsukamoto
H
H
D000818:Animals; D051545:Cyclooxygenase 1; D004064:Digestive System / Q000378:metabolism; D004731:Endotoxins / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D004790:Enzyme Induction; D005260:Female; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007422:Intestines / Q000503:physiopathology*; D007527:Isoenzymes / Q000378:metabolism; D007792:Lactulose / Q000378:metabolism; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008108:Liver Diseases, Alcoholic / Q000473:pathology* / Q000503:physiopathology*; D008297:Male; D008353:Mannitol / Q000378:metabolism; D008565:Membrane Proteins; D010539:Permeability; D011168:Portal System; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar
D004731:Endotoxins; D007527:Isoenzymes; D008070:Lipopolysaccharides; D008565:Membrane Proteins; D018799:Intercellular Adhesion Molecule-1; D008353:Mannitol; D007792:Lactulose; D051545:Cyclooxygenase 1; D011451:Prostaglandin-Endoperoxide Synthases; C496513:Ptgs1 protein, rat